Reininghaus, Ulrich
Schwannauer, Matthias
Barne, Islay
Beames, Joanne R.
Bonnier, Rafaël A.
Brenner, Manuel
Breznoščáková, Dagmar
Dančík, Daniel
De Allegri, Manuela
Di Folco, Simona
Durstewitz, Daniel
Gugel, Jessica
Hajdúk, Michal
Heretik, Anton
Izáková, Ľubomíra
Katreniakova, Zuzana
Kiekens, Glenn
Koppe, Georgia
Kurilla, Adam
Marelli, Luca
Nagyova, Iveta
Nguyen, Hoa
Pečeňák, Ján
Schulte-Strathaus, Julia C. C.
Sotomayor-Enriquez, Koraima
Uyttebroek, Lotte
Weermeijer, Jeroen
Wolters, Maria
Wensing, Michel
Boehnke, Jan R.
Myin-Germeys, Inez
Schick, Anita
Funding for this research was provided by:
Horizon 2020 (945263, 945263, 945263, 945263, 945263, 945263, 945263, 945263, 945263, 945263, 945263)
DFG (389624707)
Marie Skłodowska-Curie fellowship (101063326)
Research Foundation Flanders (1204924N)
Agentúra na Podporu Výskumu a Vývoja (APVV-22-0587)
Ruprecht-Karls-Universität Heidelberg
Article History
Received: 19 April 2024
Accepted: 13 May 2024
First Online: 24 June 2024
Declarations
:
: Approval for the study has been obtained from the Medical Ethics Committee II of Heidelberg University, Germany (No. 2022-414 MF), from the Research Ethics Committee of the West of Scotland Research Ethics Service (WoSRES) and Lothian NHS Board (Ref. No. 22-WS-0125), from the Ethics Committee of the University of Bratislava (No. 71/ 2022), and from the Ethics Committee Presovskeho Samospravneho Kraja (No. 03891/2023/OZ-4) in Slovakia. The trial received regulatory approval by competent authorities in Belgium (EUDAMED No. CIV-22-08-040547-SM01), Germany (DMIDS No. DE-22-00013961) and the Slovak Republic (EUDAMED No. CIV-SK-22-08-040547).
: Not applicable.
: The authors declare no competing interests.